Internalization of neurotensin by the neurotensin 2 receptor activates the phosphorylation of ERK1/2 in glioma cells, which is blocked by the neurotensin 2 receptor antagonist levocabastine [136]. Here, MAPK3 is linked to central nervous system cancer.